patient
Figure 3: Expression data (z-score) of luminal and basal markers in the various subtypes of breast cancer. (A): Distribution of the expression level of luminal markers CA12 (blue), AGR2 (green), TTF3 (gold), GATA3 (purple), ESR1 (yellow) and SCNN1A (red) in ER/PgR positive, HER2-enriched and TNBC patients. (B): Distribution of expression level of basal markers EN1 (blue), FOXC1 (green) and GABRP (gold) in the various subtypes of breast cancer using the same patient samples.